Childhood cancer: the long-term costs of cure
Menée aux Etats-Unis à partir des données de la cohorte "St Jude Lifetime Sudy" portant sur 5 522 patients ayant survécu à long terme (10 ans ou plus) à un cancer pendant l'enfance, cette étude rétrospective analyse leur état de santé et évalue les caractéristiques des diverses morbidités en lien avec les traitements anticancéreux
Survival after childhood cancer has substantially improved over the past several decades, and more than 80% of children diagnosed with cancer in the USA now survive at least 5 years.1 This improvement comes at a cost, however, because the curative therapies used to achieve such successful survival proportions are associated with adverse late effects, with previous research finding increased risks of morbidity,2 poor health status,3 and premature mortality4 compared with sibling and population comparison groups.
The Lancet , commentaire, 2016